enzastaurin has been researched along with Androgen-Independent Prostatic Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreicer, R; Garcia, J; Kania, M; Raghavan, D; Rini, B; Shi, P; Somer, B; Srinivas, S; Vogelzang, N | 1 |
1 trial(s) available for enzastaurin and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Double-Blind Method; Humans; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Placebos; Prostatic Neoplasms, Castration-Resistant; Taxoids; Treatment Outcome | 2013 |